New drug combo aims to lower uric acid in stubborn gout cases
NCT ID NCT07362355
First seen Jan 23, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tests whether adding a new drug (SHR4640) to a standard gout medication (febuxostat) works better than increasing the dose of febuxostat alone for people with gout and high uric acid. About 340 adults whose uric acid is still too high on 40 mg of febuxostat will take either the combination or a higher dose of febuxostat for 12 weeks. The main goal is to see if more people reach a healthy uric acid level with the combination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY GOUT AND HYPERURICEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Contact
Conditions
Explore the condition pages connected to this study.